 NEW YORK, Jan. 17, 2023 GLOBE NEWSWIRE -- IN8bio, Inc. Nasdaq: INAB, a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T cell therapies, today announced William Ho, CEO and co-founder, will present a company overview at the B. Riley Securities 3rd Annual Oncology Conference on Wednesday, January 18, 2023 at 12:00pm ET. 